Literature DB >> 22698700

Impact of preoperative rectal misoprostol on blood loss during and after elective cesarean delivery.

Mervat S-E-A Elsedeek1.   

Abstract

OBJECTIVE: To evaluate the effect of preoperative administration of rectal misoprostol on blood loss during and after elective cesarean delivery.
METHODS: A randomized controlled trial was conducted among 400 women scheduled for elective cesarean delivery. The study group (n=200) received 400 μg of misoprostol. The control group (n=200) received placebo. Study medications were administered rectally after catheter insertion and shortly before skin incision. The main outcome measures were intra-operative blood loss, postpartum blood loss at 24 hours, and difference between preoperative and postoperative hematocrit values.
RESULTS: The mean intra-operative and postpartum blood loss was significantly lower in the study group than the control group: 429 ± 234 mL and 185 ± 95 mL versus 620 ± 375 mL and 324 ± 167 mL, respectively (P=0.001 for both comparisons). The difference between the preoperative and postoperative hematocrit values was also significantly lower in the study group than the control group (4.62 ± 2.45 versus 8.15 ± 3.84; P=0.02). Admissions to the neonatal intensive care unit and Apgar scores at 1 and 5 minutes were comparable between the 2 groups.
CONCLUSION: Preoperative treatment with 400 μg rectal misoprostol significantly reduced blood loss related to elective cesarean delivery.
Copyright © 2012 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22698700     DOI: 10.1016/j.ijgo.2012.03.038

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  5 in total

Review 1.  Misoprostol to reduce intraoperative and postoperative hemorrhage during cesarean delivery: a systematic review and metaanalysis.

Authors:  Agustín Conde-Agudelo; Aníbal Nieto; Anyeli Rosas-Bermudez; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2013-03-15       Impact factor: 8.661

2.  Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Authors:  Ioannis D Gallos; Argyro Papadopoulou; Rebecca Man; Nikolaos Athanasopoulos; Aurelio Tobias; Malcolm J Price; Myfanwy J Williams; Virginia Diaz; Julia Pasquale; Monica Chamillard; Mariana Widmer; Özge Tunçalp; G Justus Hofmeyr; Fernando Althabe; Ahmet Metin Gülmezoglu; Joshua P Vogel; Olufemi T Oladapo; Arri Coomarasamy
Journal:  Cochrane Database Syst Rev       Date:  2018-12-19

3.  Rectal vs. sublingual misoprostol in cesarean section: Three‑arm, randomized clinical trial.

Authors:  Fatemeh Zahra Bagheri; Mahboobeh Azadehrah; Bizhan Shabankhani; Ebrahim Nasiri Formi; Hooshang Akbari
Journal:  Caspian J Intern Med       Date:  2022

4.  Safety and efficacy of preoperative tranexamic acid in reducing intraoperative and postoperative blood loss in high-risk women undergoing cesarean delivery: a randomized controlled trial.

Authors:  Mohamed A Shalaby; Ahmed M Maged; Amira Al-Asmar; Mohamed El Mahy; Maged Al-Mohamady; Nancy Mohamed Ali Rund
Journal:  BMC Pregnancy Childbirth       Date:  2022-03-14       Impact factor: 3.007

Review 5.  Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Authors:  Ioannis D Gallos; Helen M Williams; Malcolm J Price; Abi Merriel; Harold Gee; David Lissauer; Vidhya Moorthy; Aurelio Tobias; Jonathan J Deeks; Mariana Widmer; Özge Tunçalp; Ahmet Metin Gülmezoglu; G Justus Hofmeyr; Arri Coomarasamy
Journal:  Cochrane Database Syst Rev       Date:  2018-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.